EXPERIMENTAL
Melting points were determined on a Leica VMTG instrument (Germany). Optical rotation was measured on a
Perkin–Elmer Model 343 polarimeter (Germany). UV spectra were taken in MeOH on a CECIL, CE 7250, 7000
spectrophotometer (England). IR spectra were recorded in CHCl on a Bruker OPUS Vector-22 spectrophotometer. PMR and
3
13
C NMR spectra were measured on a Bruker DRX-500 (500 and 125.6 MHz) spectrometer with TMS internal standard.
High-resolution electron-impact mass spectra were taken on anAMD 604 S spectrometer (Germany). Column chromatography
was carried out over silica gel L (40/100 ꢀm, Chemapol, Czechoslovakia) and Sephadex LH-20 (Pharmacia Biotech, Sweden).
Silica-gel plates (4.5 ꢇ 6.0 cm, 5–17 ꢀm, Sorbfil, Russia) were used for TLC.
Cultivation of Fungus. The fungus Myceliophthora lutea was isolated from marine sediments of Sakhalin Bay (Sea
of Okhotsk, 32 m depth) and cultivated for three weeks on standing at 22°C in six 1-L flasks, each of which contained medium
consisting of wort (50 mL), agar (5 g), and seawater (200 mL).
Extraction and Isolation of 1–4. Fungal mycelium was extracted with EtOAc (2.5 L). The solvent was evaporated.
The solid (2.5 g) was treated with H O:EtOH (4:1, 200 mL). The resulting suspension was extracted successively with hexane
2
(200 mL ꢇ 2), CHCl (200 mL ꢇ 2), and n-BuOH (100 mL ꢇ 2). The CHCl extract was evaporated. The solid (900 mg) was
3
3
chromatographed over a column (20 ꢇ 2 cm) of silica gel using hexane:EtOAc (95:5, 90:10, 85:15, 80:20). Gel filtration over
Sephadex LH-20 in CHCl afforded pure 1 (5 mg), 2 (57 mg), 3 (15 mg), and 4 (9 mg). Compounds 3 and 4 were not present
3
in the starting EtOAc extract and were formed during the isolation process. This was confirmed experimentally.
Conversion of Acremine A (2) to Spiroacremines A (3) and B (4). Acremine A (16 mg) was dissolved in CHCl
3
(5 mL) and left on a table. Two compounds in addition to acremine A were observed in the solution after a week according to
TLC. The solution was evaporated. The resulting mixture was separated using column chromatography over silica gel and
hexane:EtOAc (95:5–80:20) to afford 1 (8 mg), 3 (5 mg), and 4 (3 mg). Longer storage (about one month) of acremine A in
CHCl solution transformed it completely to the spiroacremines.
3
Isoacremine D (1), C H O , white crystals, mp 260–262°C (hexane:EtOAc, 9:1). UV spectrum (EtOH, ꢈ ,
12 14
3
max
–1
nm): 203, 249, 295 (log ꢉ 4.22, 3.96, 3.60). IR spectrum (CHCl , , cm ): 3605, 2928, 1737, 1602. High-resolution mass
spectrum (EI): found: m/z 206.0949 [M] ; calcd: 206.0943. Table 1 presents NMR spectral data for 1.
3
+
20
Acremine A (2), C H O , white crystals, mp 121–123°C (hexane:EtOAc, 9:1), [ꢆ] +12.1° (c 0.31, EtOH).
12 18
4
D
–1
UV spectrum (EtOH, ꢈ , nm): 281 (log ꢉ 4.05). IR spectrum (CHCl , , cm ): 3467, 3330, 1681, 1639, 1598. High-
resolution mass spectrum (EI): found: m/z 226.1221 [M] ; calcd: 226.1205. Table 2 presents NMR spectral data for 2.
max
3
+
20
Spiroacremine A (3), C H O , white crystals, mp 128–131°C (hexane:EtOAc, 8:1), [ꢆ] +18° (c 0.3, EtOH).
12 18
4
D
–1
UV spectrum (EtOH, ꢈ , nm): 217, 281 (log ꢉ 2.92, 2.10). IR spectrum (CHCl , , cm ): 3571, 3494, 2979, 2932, 1721,
1602. High-resolution mass spectrum (EI): found: m/z 226.1209 [M] ; calcd: 226.1205. Table 3 presents NMR spectral data
for 3.
max
3
+
Preparation of (S)- and (R)-MTPA (methoxy trifluoromethyl phenyl acetic acid) Esters of Spiroacremine A
(3a and 3b). A solution of 3 (2 mg) in Py (200 ꢀL) was treated with several crystals of 4-dimethylaminopyridine and
(R)-MTPA-Cl (20 ꢀL). The resulting mixture was left for 1 h at room temperature. The solvent was evaporated. The solid was
chromatographed over silica gel using hexane:EtOAc (95:5) to afford the (S)-MTPA ester 3a (3 mg). The (R)-MTPA ester 3b
was prepared in the same manner using (S)-MTPA-Cl.
(S)-MTPA Ester (3a). PMR spectrum (CD OD, ꢁ, ppm, J/Hz): 5.89 (1H, d, J = 5.7, H-3), 5.66 (1H, d, J = 5.7,
3
H-4), 5.49 (1H, dd, J = 5.4, 11.6, H-10), 3.49 (3H, s, OMe), 3.14 (1H, d, J = 14.7, H-6ꢆ), 2.31 (1H, d, J = 14.7, H-6ꢅ), 2.15
(1H, dd, J = 5.1, 12.0, H-9ꢆ), 2.11 (1H, t, J = 12.0, H-9ꢅ), 1.48 (3H, s, Me-1ꢃꢃꢃ), 1.23 (3H, s, Me-1ꢃ), 1.03 (3H, s, Me-1ꢃꢃ),
+
7.39-7.57 (5H, m, Ph). Mass spectrum (EI): m/z 442 [M] .
(R)-MTPA Ester (3b). PMR spectrum (CD OD, ꢁ, ppm, J/Hz): 5.38 (1H, d, J = 5.7, H-3), 5.38 (1H, m, J = 5.7,
3
H-4), 5.49 (1H, dd, J = 4.8, 12.0, H-10), 3.58 (3H, s, OMe), 3.12 (1H, d, J = 14.7, H-6ꢆ), 2.26 (1H, d, J = 14.7, H-6ꢅ), 2.22
(1H, dd, J = 4.8, 11.7, H-9ꢆ), 2.32 (1H, t, J = 12.0, H-9ꢅ), 1.49 (3H, s, Me-1ꢃꢃꢃ), 1.15 (3H, s, Me-1ꢃ), 0.83 (3H, s, Me-1ꢃꢃ),
+
7.38–7.49 (5H, m, Ph). Mass spectrum (EI): m/z 442 [M] .
20
Spiroacremine B (4), C H O , white crystals, mp 142–145°C (hexane:EtOAc, 8:1), [ꢆ] +4.2° (c 0.24, EtOH).
12 18
4
D
–1
UV spectrum (EtOH, ꢈ , nm): 215, 281 (log ꢉ 3.37, 2.39). IR spectrum (CHCl , , cm ): 3600, 3500, 2977, 2929, 1719,
max
3
+
1602. High-resolution mass spectrum (EI): found: m/z 226.1195 [M] ; calcd: 226.1205. Table 4 presents NMR spectral data
for 4.
389